The human papilloma virus vaccine (Gardasil) may provide cross-protection against 10 strains of the virus, in addition to the 4 strains it targets, according to an Associated Press story. The vaccine's manufacturer, Merck, presented the data yesterday at the Interscience Conference on Antimicrobial Agents and Chemotherapy.
The vaccine may now protect against 90% of the strains that cause cervical cancer.
Women should still get regular Pap smears because the vaccine does not cover all HPV strains, Michael Segarra, of North Brunswick (New Jersey) Pediatrics, told the AP.
No comments:
Post a Comment